These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 6821030)

  • 1. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].
    Xu CH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
    Wu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
    [No Abstract]   [Full Text] [Related]  

  • 3. [Application of SP-RIA in the antibody surveillance and serologic diagnosis of epidemic cerebrospinal meningitis].
    Chen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):366-70. PubMed ID: 8156584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report.
    Lepow ML; Gold R
    N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccines against meningococcal meningitis: current status.
    Epidemiol Bull; 1994 Jul; 15(2):13-5. PubMed ID: 8086300
    [No Abstract]   [Full Text] [Related]  

  • 6. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
    Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE
    Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.
    Peltola H; Mäkelä H; Käyhty H; Jousimies H; Herva E; Hällström K; Sivonen A; Renkonen OV; Pettay O; Karanko V; Ahvonen P; Sarna S
    N Engl J Med; 1977 Sep; 297(13):686-91. PubMed ID: 408682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial of a serogroup A meningococcus polysaccharide vaccine in Nigeria.
    Sanborn WR; Bencić Z; Cvjetanović B; Gotschlich EC; Pollock TM; Sippel JE
    Prog Immunobiol Stand; 1971; 5():497-505. PubMed ID: 4633977
    [No Abstract]   [Full Text] [Related]  

  • 9. [efficacy of the polysaccharide vaccine of Neisseria meningitidis group A].
    Yuan CD
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):207-10. PubMed ID: 6416682
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.
    Ambrosch F; Wiedermann G; Crooy P; George AM
    Bull World Health Organ; 1983; 61(2):317-23. PubMed ID: 6407768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children.
    Lepow ML; Beeler J; Randolph M; Samuelson JS; Hankins WA
    J Infect Dis; 1986 Dec; 154(6):1033-6. PubMed ID: 3097160
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of 2 vaccination strategies on developments during the epidemic of meningococcal A meningitis in N'Djamena (Chad) in 1988].
    Spiegel A; Greindl Y; Lippeveld T; Decam C; Granga D; Nahor N; Bordonado JL; Sperber G; Yankalbe M; Baudon D
    Bull World Health Organ; 1993; 71(3-4):311-5. PubMed ID: 8324849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right age for Meningococcal vaccine.
    John TJ
    Indian Pediatr; 1998 Jul; 35(7):669-70. PubMed ID: 10216680
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vaccines against Neisseria meningitidis].
    Ferrón L; Criado MT; Ferreirós CM
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):296-301. PubMed ID: 1391002
    [No Abstract]   [Full Text] [Related]  

  • 15. Should we plan a general childhood vaccination against bacterial meningitis?
    Mäkelä PH; Peltola H
    Dev Biol Stand; 1979; 43():61-7. PubMed ID: 42596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination.
    Mohammed I; Onyemelukwe GC; Obineche EN; Gupta N; Oyeyinka GO
    J Infect; 1984 Sep; 9(2):197-202. PubMed ID: 6438245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Observation on the epidemiologic efficacy for 9 years on epidemic meningococcal polysaccharide vaccine of group A by district immunization method].
    Ma Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Apr; 12(2):69-71. PubMed ID: 2065343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococci.
    Sippel JE
    Crit Rev Microbiol; 1981; 8(3):267-302. PubMed ID: 6781818
    [No Abstract]   [Full Text] [Related]  

  • 19. [Meningococcal disease in the Netherlands; after low tide another high tide?].
    Zanen HC
    Ned Tijdschr Geneeskd; 1984 Mar; 128(11):515-8. PubMed ID: 6424036
    [No Abstract]   [Full Text] [Related]  

  • 20. [The antimeningococcal vaccination campaign in Cantabria, February-March 1997].
    González de Aledo Linos A
    An Esp Pediatr; 1998 Jan; 48(1):98-9. PubMed ID: 9542236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.